Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus
Clinical trial NCT06691152 · RECRUITING
Trial details
- NCT number
- NCT06691152
- Sponsor
- The Children's Hospital of Zhejiang University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-30
- Primary completion
- 2027-09-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.